Literature DB >> 27061348

The outcomes of scleral buckling versus re-vitrectomy for the treatment of recurrent inferior retinal detachment in silicone oil tamponade eyes.

Yong Wei1,2, Guoji Wu3, Kui Xu4, Jianzhou Wang5, Zhongqiao Zu5, Rui Wang5.   

Abstract

PURPOSE: In this retrospective study we evaluated the anatomic outcomes of scleral buckling (SB) versus re-vitrectomy for the treatment of recurrent inferior retinal detachment (RD) in silicone oil (SiO) tamponade eyes after primary vitrectomy.
METHODS: There were 103 patients (103 eyes) enrolled in this study. All patients had recurrent inferior RD in the SiO-filled eyes within 6 months after the primary vitrectomy, and were treated by either SB or re-vitrectomy. Patients were divided into two groups based on different surgical procedures: the SB group (49 eyes) and the re-vitrectomy group (54 eyes). Anatomic reattachment of the retina was measured after reoperation. Based on different retinal proliferation states in different postoperative periods after primary vitrectomy, we also compared the anatomic outcomes of the two surgical procedures in two specific postoperative periods, early period (≤1 month) and late period (1-6 months).
RESULTS: The SB and re-vitrectomy groups exhibited similar retinal reattachment rate (65.3% versus 72.2%, p = 0.449) after reoperation. In the re-vitrectomy group, the retinal reattachment rate was similar in the early period and the late period (70.8% versus 73.3%, p = 0.839). However, the retinal reattachment rate was significantly higher in the early period than that of the late period (80.8% versus 47.8%, p = 0.016) in the SB group. In the early surgery groups, the retinal reattachment rate was similar in the SB group compared to the re-vitrectomy group (80.8% versus 70.8%, p = 0.411). While in the late surgery groups, retinal reattachment rate was trended higher in the re-vitrectomy group compared to the SB group (73.3% versus 47.8%, p = 0.058).
CONCLUSION: For recurrent inferior RD in SO-filled eyes, SB surgery provides similar therapeutic effectiveness with satisfactory anatomic outcomes compared to the re-vitrectomy. For eyes with recurrent inferior RD in the early period (≤1 month) after primary vitrectomy, SB surgery may be a better choice since it causes less complication; while in the late period (1-6 months) after primary vitrectomy, re-vitrectomy may be recommended, especially for the eyes with severe anterior proliferative vitreoretinopathy and retinal foreshortening.
© 2016 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  retinal detachment; scleral buckling; silicone oil; vitrectomy

Mesh:

Substances:

Year:  2016        PMID: 27061348     DOI: 10.1111/aos.13037

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  5 in total

1.  Surgical outcomes in inferior recurrences of rhegmatogenous retinal detachment.

Authors:  Sergey V Churashov; Tatiana N Shevalova; Alexei N Kulikov; Dmitrii S Maltsev
Journal:  Int J Ophthalmol       Date:  2021-12-18       Impact factor: 1.779

2.  Ocular movement disorders following scleral buckling surgery: A case series study.

Authors:  Mohammad Reza Akbari; Arash Mirmohammadsadeghi; Ali Makateb; Fariba Ghassemi; Amir Hossein Norooznezhad; Alireza Khodabande; Sakineh Kadivar; Vahid Mohammadzadeh
Journal:  J Curr Ophthalmol       Date:  2018-10-07

3.  Outcome of scleral buckling with or without gas tamponade for recurrent retinal detachment in post-vitrectomy eyes.

Authors:  Jun-Xing Bai; Xiao-Jian Zhang; An-Li Duan; Xiao-Yan Peng
Journal:  BMC Ophthalmol       Date:  2021-02-27       Impact factor: 2.209

Review 4.  Management of recurrent rhegmatogenous retinal detachment.

Authors:  Manish Nagpal; Pranita Chaudhary; Shachi Wachasundar; Ahmed Eltayib; Aparajita Raihan
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

5.  Adequate Silicone Oil Tamponade by Utilizing the Space of Anterior Segment for Complicated Retinal Detachment: Technique, Efficacy, and Safety.

Authors:  Yifan Wang; Zijing Huang; Dezhi Zheng; Juntao Liu; Dingguo Huang; Jianlong Zheng; Haixia Xie; Peimin Lin; Weiqi Chen
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2021-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.